Indications and Purposes
1 Indications And Usage • Empliciti Is Indicated In Combination With Lenalidomide And Dexamethasone For The Treatment Of Adult Patients With Multiple Myeloma Who Have Received One To Three Prior Therapies. • Empliciti Is Indicated In Combination With Pomalidomide And Dexamethasone For The Treatment Of Adult Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies Including Lenalidomide And A Proteasome Inhibitor. Empliciti Is A Slamf7-Directed Immunostimulatory Antibody Indicated In • Combination With Lenalidomide And Dexamethasone For The Treatment Of Adult Patients With Multiple Myeloma Who Have Received One To Three Prior Therapies. (1) • Combination With Pomalidomide And Dexamethasone For The Treatment Of Adult Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies Including Lenalidomide And A Proteasome Inhibitor. (1) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Elotuzumab |